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1. Introduction 
A total hysterectomy is the most common type of gynecologic surgery and may be 
performed to treat many diseases that affect the uterus including: abnormal uterine 
bleeding, uterine fibroids, endometriosis and chronic pelvic pain, anatomic uterine defects, 
uterine prolapse and cancer (Reich, 2003). Based on German studies from 2005 and 2006 
(overall 305 015 hysterectomies performed during the study period) the hysterectomy rate 
for benign diseases of the genital tract among women aged 20 or older (3.6 out of 1000 
women) was higher than in Sweden but lower than in the US or Australia (Gupta, 2006, 
Stang 2011). The United States still has the highest incidence of hysterectomy, with about 
550 000 women undergoing this operation annually, at a cost of more than $5 billion. The 
rate of this procedure in the USA is 5.4/1000 women, whereas in Italy it is 3.7/1000 and in 
Norway only 1.2/1000 women (Manyonda, 2003).  
The hysterectomy can be done in different ways. These procedures can be performed using 
one of three main approaches: laparoscopic hysterectomy (LH), abdominal hysterectomy 
(AH) and vaginal hysterectomy (VH) (Clayton 2006). In laparoscopic, abdominal and 
vaginal hysterectomy can we removal of the uterus and cervix with/or without removal of 
ovaries. Table 1 show three main procedures of hysterectomy and surgery extension of 
female organs (tab.1).  
Laparoscopic hysterectomy  Abdominal hysterectomy 
Vaginal 
hysterectomy 
Complete removal of the uterus 
and with/or without cervix 
with/or without removal of 
ovaries. Lymph nodes, ovaries 
and fallopian tubes can also be 
removed in this situation. 
Removal of the uterus, cervix, 
upper vagina, and 
parametrium. Lymph nodes, 
ovaries and fallopian tubes 
can also be removed in this 
situation. 
Removal of the 
uterus, cervix 
with/or without 
removal of ovaries 
Table 1. Three main procedures of hysterectomy 
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The type of hysterectomy depends on the reason for the surgery and other factors for 
example age or general health condition and main disease and expertise, as the indications 
for each technique overlap. VH is probably the preferred route because it is quicker and 
cheaper than LH, with no other clear differences in outcome measures. LH has a number of 
advantages over AH like specifically, shorter hospital stay and quicker return to normal 
activities; complication rates, however, appear to be greater (Clayton 2006). In gynecological 
practice in the UK and the USA, 60–80% of all hysterectomies are performed by the 
abdominal route. In one of the German studies for all performed hysterectomies only 6% 
were laparoscopically assisted vaginal hysterectomies and 5% laparoscopic hysterectomies. 
10% of laparoscopical hysterectomies and 1% of vaginal hysterectomies necessitated a 
conversion to an abdominal hysterectomy (Stang 2011).  
There are three basic types of hysterectomy: total hysterectomy, supracervical also called 
subtotal or partial hysterectomy and radical hysterectomy. All these procedures can be 
conducted with or without the removal of the ovaries and the fallopian tubes on one or both 
sides (Tab. 2).  
Total hysterectomy Subtotal hysterectomy Radical hysterectomy 
Complete removal of 
the uterus and cervix 
with/or without 
removal of fallopian 
tubes and ovaries 
Removal of the uterus, 
leaving the cervix 
with/or without 
removal of fallopian 
tubes and ovaries 
Removal of the uterus, cervix, 
upper vagina, and parametrium. 
Lymph nodes, ovaries and fallopian 
tubes are also usually removed in 
this situation. 
Table 2. Three basic types of hysterectomy 
The ACOG (American Congress of Obstetricians and Gynecologists) has suggested that 
concomitant bilateral oophorectomy should be performed during the hysterectomy for 
benign uterine diseases in peri- and postmenopausal women. Strong consideration should 
be made for retaining normal ovaries in premenopausal women who are not at increased 
genetic risk of ovarian cancer. In Germany, 4% and 26% of all hysterectomies for benign 
diseases of the genital tract included bilateral oophorectomy among peri- and 
postmenopausal women respectively. The highest hysterectomy rates were among women 
aged 40–49 years (9.9 per 1,000 women) (Stang 2011). Twenty-six percent of hysterectomies 
for benign diseases among women aged 50 or older were bilateral oophorectomy. Another 
study conducted in the USA showed that 37% of hysterectomies among women with benign 
diseases of the genital tract aged 15–44 years were accompanied by bilateral oophorectomy. 
2. Abdominal hysterectomy procedures  
2.1 General information on abdominal hysterectomy procedures  
A hysterectomy (from Greek ὑǔǕέρα hystera "womb" and εκǕομία ektomia "a cutting out of") 
is the surgical removal of the uterus. Hysterectomy is the second most commonly performed 
surgical procedure in the United States after cesarean delivery (Falcone, 2008). 
Hysterectomy is a common procedure in Australia; approximately 1 in 5 Australian women 
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undergoing a hysterectomy by the age of 50 for indications such as fibroids, disorders of 
menstruation (including excessive or irregular menstrual bleeding), and endometriosis 
(Graham, 2008).  
In the management of early-stage cancer a radical hysterectomy can be performed (Panici, 
2011). The most commonly used definition was proposed by Pivera, Rytledge’a and Smitha 
(tab.3). Five classes (class I–V) of extended hysterectomy were described. Class II and Class 
III are the most commonly employed (Piver 1974; Clayton 2006).  
Type of surgery Scope of procedure 
Class 1 Outer facial surgical excision of the uterus. As a master of fact it is 
not a radical hysterectomy, it comprises only pushing the ureters 
away laterally without their preparation, which allows to  
clamp the vagina. The uterus is removed with an additional margin 
of the parametrium and the vagina. 
Class 2 Excision of the uterus along with the primary ligament which is 
intersected centrally in relation to the ureter. Excision of the  
sacro-uterine ligaments in the middle of their length and 1/3 of the 
upper vagina. 
Class 3 It assumes the intersection of the primary ligaments laterally  
from the ureter by the pelvic wall and the intersection of the sacro-
uterine ligaments as close to the sacrum as possible, i.e. 
hysterectomy with the removal of the entire broad and sacro-uterine 
ligaments as well as 1/2 of the vagina. 
Class 4 Excision of the uterus and the periuretal tissue, resection  
of the upper vesical artery 3/4 of the vagina 
Class 5 Excision of the urinary bladder with distal ureteral  
segments. 
Table 3. Types of operations according to Piver, Rytledge and Smith (Piver 1974) 
Laparotomy is still considered the standard approach for radical hysterectomy; however, 
the total extraperitoneal abdominal radical hysterectomy (TEARH) has been described as a 
valid alternative for pelvic lymphadenectomy, with shorter operative time, shorter ileus and 
reduced postoperative pain and hospitalization (Panici, 2011).  
2.2 Indications and contraindications 
2.2.1 General indications for abdominal hysterectomy 
General, noncancer indications for the abdominal surgeries of the removal of the uterus 
include: uterus ''too big'' or vagina ''too narrow'' (pubic arch < 90 degrees, bituberous 
diameter < 8.0 cm), uterus ''too high'' or ''will not come down'' also intra-abdominal 
conditions contraindicate vaginal approach (adhesions, endometriosis, adnexal disease, 
previous pelvic surgery, chronic pelvic pain, previous cesarean delivery) (Kovac, 2004; 
Learman, 2011). The indications for AH or VH in 2005 have changed little over the last 
decade, with uterine leiomyomata (33%) and being the most common, followed by prolapse 
(13%) and endometriosis (9%) (NIS 2007; Falcone 2008) . One should not forget that one of 
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the indications for hysterectomy is sex reassignment. The predictors of hysterectomy is also 
performs as a treatment for menstrual problems (Graham, 2008).  
Indications for radical surgeries depend on the severity and type of tumour show the table 
(tab.4). 
Type of surgery Indications 
Class 1 Preinvasive carcinoma, early invasion 
Class 2  Neoplastic invasion greater than in class 1. 
Class 3  Clinical severity 1b, 2a 
Class 4 Neoplastic process involving the bladder and distal ureteral 
segments 
Class 5 Neoplastic process involving the bladder and distal ureteral 
segments 
Table 4. Types of surgeries 
2.2.2 Obstetrical hysterectomy 
Perinatal hysterectomy is the removal of the uterus immediately after delivery or caesarean 
section or up to 24 hours after delivery or cesarean section. It is a difficult procedure, 
performed rarely usually due to emergency indications, burdened with a high risk of 
postoperative complications. It is often a consequence of previously performed caesarean 
section and accompanying complications such as uterine rupture in the scar or bleeding 
from the villi of the placenta located on the front wall of the uterus, which grow into the scar 
(Poręba, 2007).  
Flood et al. (Flood et all, 2009) was performed a retrospective cohort study from 1966-2005 
of patients who had peripartum hysterectomy (PH). There were 872,379 deliveries during 
the study period, among which 358 women underwent PH (0.4/1000 deliveries). In a 
comparison of the study decades 1966-1975 with 1996-2005, peripartum hysterectomy 
decreased from 0.9 per 1000 deliveries to 0.2 of 1000 deliveries. Although the overall 
cesarean delivery rate has increased from 6-19% during these 2 decades, the percentage of 
peripartum hysterectomy that occurs in the setting of a previous cesarean delivery has 
increased from 27-57% (P < .00001). According to the authors, main indications for PH had 
changed significantly in this time period, with “uterine rupture” as the indication for 
peripatum hysterectomy decreasing from 40.5-9.3% (P < .0001) and placenta accreta as the 
indication increasing significantly from 5.4-46.5% (P < .00001) (Flood et all, 2009). Poręba et 
all. (Poręba et all,) had analysed 63 232 labours between 1980-2005. 10 317 deliveries were 
eventually managed by caesarean section, and the emergency peripartum hysterectomy was 
necessary in 39 cases after labour in Department of Gynecology and Obstetrics Medical 
University of Silesia in Poland. In the opinion of the researchers, peripartum and 
intraoperational haemorrhage being a result of uterine atony was the most frequent cause of 
emergency peripartum hysterectomy (Poręba et all, ). Shellhaas et all (Shellhaas, 2009) were 
described a total of 186 cesarean hysterectomies (0.5%) which were performed from a cohort 
of 39,244 women who underwent cesarean delivery. The leading indications for 
hysterectomy were placenta accreta (38%) and uterine atony (34%). Of the hysterectomy 
cases with a diagnosis recorded as accreta, 18% accompanied a primary cesarean delivery 
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while 82% had a prior procedure (p<0.001). Of the hysterectomy cases with atony recorded 
as a diagnosis, 59% complicated primary cesarean delivery whereas 41% had a prior 
cesarean (p< 0.001). Major maternal complications of cesarean hysterectomy included 
transfusion of red blood cells (84%) and other blood products (34%), fever (11%), subsequent 
laparotomy (4%), ureteral injury (3%), and death (1.6%). Accreta hysterectomy cases were 
more likely than atony hysterectomy cases to require ureteral stents (14% versus 3%, p=0.03) 
and to instill sterile milk into the bladder (23% versus 8%, p=0.02) (Shellhaas, 2009). 
Peripatum hemorrhage remains a cause of significant maternal morbidity and mortality. 
Accurate diagnosis and appropriate management of obstetric hemorrhage can reduce 
maternal morbidity and mortality worldwide (Kuczkowski, 2009). 
2.3 Complications of hysterectomy and the quality of life 
Hysterectomy is one of the safest surgical procedures. Overall mortality rate is 0,5-2/1000. 
The complications are most common in women treated for uterine fibroids, within the 
group on which hysterectomy performed for benign gynecological indications and overall 
rate decreases with age (Manyonda, 2003). 
The advantages of abdominal hysterectomy are: good access into the peritoneal cavity, wide 
access to the site of operation and easier technique to remove appendages. At the same time, 
this traditional method of hysterectomy has many disadvantages associated with abdominal 
incision and greater operational trauma (Barwijuk 2005).  
The complications of hysterectomy may occur during the operation or a few days, weeks, or 
even years after the surgery. Intraoperative complications include: bladder and urethra 
injury, bowel injury and also vascular injury with bleeding that requires transfusion. Short-
term complications are connected with vaginal and sometimes urinary infection. Long-term 
side effects of hysterectomy are fistula and bladder dysfunction or prolapse. Many women 
complain of chronic pain. These complications are more common after an abdominal 
hysterectomy.  
One of the long-term complications of gynecological surgeries is urinary incontinence. The 
aim of the study conducted by Jędrzejczyk et al. (Jędrzejczyk, 2008) was to assess the 
prevalence of urinary incontinence after some gynecological-obstetrical surgeries and to 
specify the type of incontinence, depending on the type of surgery and its access, in groups 
of premenopausal and postmenopausal patients. It appears that abdominal and vaginal 
accesses equally predispose to stress urinary incontinence (SUI). After abdominal 
hysterectomy the most common is SUI, while after caesarean section mixed urinary 
incontinence (MUI). Urgent UI is more common after vaginal plastic surgeries than after 
abdominal surgeries (Jędrzejczyk, 2008). However, the proportion of patients with urinary 
incontinence is lower by 50% in patients after over cervical amputation than after 
hysterectomy, and thus it should be a reason to consider the possibility of limiting the scope 
of the surgery in postmenopausal patients in order to prevent urinary incontinence. 
Obviously, it requires providing thorough information about the prevention of cervical 
cancer and further regular cytological testing (Jędrzejczyk, 2008). Forsgren et al. (Forsgren, 
2009) observed that the pelvic organ fistula surgery was four times more common in women 
after hysterectomy compared with women not having the procedure. The highest fistula 
rates were observed the first year after surgery (Forsgren, 2009). 
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In case of patients who cannot be operated in a preserving way due to their serious diseases, 
a new technique of radical hysterectomy which saves the vegetative nervous system 
(RHOUW) should be considered. Nerve - sparing technique reduces the number of side effects 
from the urinary tract, and enables to perform the surgery with the same extent as in 
traditional nerve-sparing radical hysterectomy, giving identical oncological results (Maas, 
2005; Raspagliesi, 2003; Sakuragi, 2005; Fujii, 2007; Kalemli, 2005). A comparative study of 
Sakuragi et al. (Sakuragi, 2005) analyzing a group of patients who have had RHOUW and 
a group in which an attempt to perform this surgery failed, clearly shows that after one year 
of observation urinary incontinence and reduced sensation in the bladder has not occurred 
in the group after RHOUW, and appeared in 100% of patients after classic radical 
hysterectomy (Sakuragi, 2005). In addition, Sasaki et al (Sasaki, 1982) reported that radical 
hysterectomy was followed by the reduction of maximum urethral closure pressure, which 
was probably related to the damage of the abdominal nerve (Sasaki, 1982). A paper by 
Morgan et al. (Morgan, 2000) showing the relationship of the radical hysterectomy with 
urethral sphincter insufficiency (ISD) on the basis of leek point pressure (LPP) in the 
urodynamic study would confirm these findings (Morgan, 2000).  
3. Laparoscopic hysterectomy  
3.1 General information on laparoscopic hysterectomy procedures  
Laparoscopic hysterectomy includes both vaginal excision of the uterus, where the 
endoscopic part of the surgery consists in releasing adhesions or intersecting some 
ligaments and uterine vessels, as well as a radical removal of the uterus with the 
parametrium, vaginal cuff, and the lymph nodes, where all operations are performed 
laparoscopically, and the extraction of the uterus takes place not through the vagina 
(Barwijuk, 2005; Lee, 2002). 
The type of laparoscopic hysterectomy is usually defined by the extent of laparoscopic 
dissection performed during the procedure (LAVH, LH, TLH, Robot-assisted laparoscopic 
hysterectomy). Table 5 show the type of surgical technique on laparoscopic hysterectomy 
procedures. 
The concept of laparoscopic hysterectomy is therefore not so wide. Each procedure in which 
the uterus is extracted from the abdominal cavity through the vagina is in fact 
a laparoscopically assisted vaginal hysterectomy – as in LAVH, or a laparoscopically 
assisted total vaginal hysterectomy - as in LATVH, or a laparoscopically assisted radical 
vaginal hysterectomy - as in LAVRH. Only LSH and LTH are laparoscopic hysterectomy 
surgeries, and in both cases the uterus is extracted by means of a laparoscopic morcellation.  
3.2 Indications and contraindications for laparoscopic hysterectomy 
The development of laparoscopy has made it an essential and irreplaceable element in 
modern gynaecology, both in the diagnostic and therapeutic process. Currently, the  
scope of laparoscopic surgeries is wide and includes almost all procedures performed by 
laparotomy, thus eliminating the consequences such as extensive postoperative scars 
(Malinowski, 2009). Nevertheless, the indications for different types of laparoscopic 
hysterectomy are different. Indications for various laparoscopic surgeries show table 6.  
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Type of surgical technique Detailed scope of procedure 
Laparoscopic Supracervical 
Hysterectomy 
The technique of the procedure is based on cutting off 
ligamentum teres uteri and infundibulo-pelvicum or ovarian 
ligaments, intersection of both plaques of the broad ligament 
of the uterus, closure of the lumen of both uterine arteries, 
and cutting off the uterine body from the cervix. In the next 
stage, the uterine body is extracted from the peritoneal cavity 
using morcellator. 
Laparoscopically Assisted 
Vaginal Hysterectomy 
The technique of the operation is based on cutting off primary 
ligaments and uterosacral ligaments from the laparoscopic 
access and cutting off the uterus from the vaginal vault from 
the vaginal access.  
Laparoscopic Total 
Hysterectomy 
The uterus is cut off from the vaginal vault, the vaginal stump 
is stitched up and the preparation is extracted from the 
abdominal cavity by a morcellator. 
Laparoscopic Total Radical 
Hysterectomy and Pelvic 
Lymphadenectomy 
After removal of all levels of the pelvic lymph nodes, the next 
step is to remove the uterus through the abdominal wall.  
Laparoscopically Asissted 
Total Vaginal 
Hysterectomy 
All stages of the operation with cutting off the uterus from 
the vaginal vault are performed laparoscopically. The 
extraction of the preparation and stitching of the vaginal 
stump is conducted from the vaginal access. 
Laparoscopically Assisted 
Radical Vaginal 
Hysterectomy 
After removal of all levels of the lymph nodes, the next step 
of LARVH is to remove the uterus through the vagina. 2 
types of operations are performed, depending on the extent: 
either like in type 2 according to Piver and Rutledge, or in a 
more radical way according to Schaut-Amreich. It is similar to 
hysterectomy conducted from the abdominal access, 
classified as type 3 according to Piver and Rutledge. 
Table 5. Types of hysterectomy procedures using a laparoscope (Chapron, 1996; Parker, 
2000; Dargent, 2001; Barwijuk, 2005; Lee, 2002, Vizza, 2011).  
Kruijdenberg et al. (Kruijdenberg, 2011) reviewed current literature on total laparoscopic 
(TLRH) and robot assisted radical hysterectomy (RRH) with pelvic lymphadenectomy in the 
treatment of early stage cervical cancer. He analyzed 27 studies comprising 342 RRH 
patients and 914 TLRH patients. There was no statistical difference between the methods in 
terms of age, BMI or prior abdominal surgery. Estimated mean operative time, blood loss 
and number of lymph nodes retrieved did not statistically differ between the RRH and 
TLRH method. Less blood transfusions were needed in patients treated by RRH versus 
TLRH (5.4% vs 9.7%, p<0.05). Both methods were similar in respect to adjuvant chemo- or 
(chemo) radiation and recurrence rate. When complications were prioritized in severity, 
major post-operative complications where more frequent in RRH patients than in TLRH 
patients (9.6% vs 5.5%, p<0.05). The length of hospital stay was significantly shorter in RRH 
compared to TLRH treatment (3.3 versus 6.2 days respectively; p=0.04). According to the 
authors, robot-assisted and total laparoscopic radical hysterectomy appears to be equally 
adequate and feasible. RRH studies had small patient populations and further experience  
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Laparoscopic 
surgeries 
procedures 
Indications for various laparoscopic surgeries 
LSH Symptomatic myomas of the uterus, overgrowth of the uterine 
mucosa, heavy uterine bleeding resistant to pharmacotherapy, 
adenomiosis and endometriosis, and pelvic pain syndrome 
LAVH Symptomatic myomas of the uterus, overgrowth of the uterine 
mucosa, heavy uterine bleeding resistant to pharmacotherapy, 
adenomiosis and endometriosis, and pelvic pain syndrome. 
Alternatively additionally extended by cervical pathologies, such as 
e.g. dysplasia and early neoplasia 
LTH Symptomatic myomas of the uterus, overgrowth of the uterine 
mucosa, heavy uterine bleeding resistant to pharmacotherapy, 
adenomiosis and endometriosis, and pelvic pain syndrome, 
alternatively additionally extended by cervical pathologies, such as 
e.g. dysplasia and early neoplasia. Patients who did not give birth 
and who have been diagnosed with uterine myomas with a 
diameter larger than 5 cm by ultrasonography, with the uterus 
weighing more than 300 g and with non-malignant lesions in 
appendages which accompany uterine pathology. 
LATVH Pelvic organ prolapse accompanying a main disease, requiring 
surgery and perineal laceration repair. 
LARVH It is performed exclusively in oncological indications, i.e. in the 
early stages of ovarian cancer, cervical cancer and endometrial 
cancer. Ovarian cancer is a controversial indication and many 
clinicians are of the opinion that in this case laparoscopy should be 
replaced with a radical abdominal surgery. 
LRH Can be performed in stage Ia2–Ib1 or less advanced node negative 
cervical cancer patients without compromising survival. The 
feasibility of LRH for more advanced patients needs further 
investigations. 
TLRH Can be safely performed in patients with stage IB2-IIB carcinoma of 
cervix after NACT, with advantages of minimal blood loss and 
morbidity (can be performed in stage IB2-IIB with complete clinical 
response after 3 courses of NACT with paclitaxel 175 mg/m2, 
ifosfamide 5 g/m2 and cisplatin 75 mg/m2.  
Table. 6. Indications for various laparoscopic surgeries (Malinowski, 2009; El-Mowafi, 2004; 
Chapron, 1996; Parker, 2000; Reich, 1990 & 2003; Childers, 1992; Querleu, 1991; Skręt, 2003; 
Vizza, 2011; Yan, 2011). 
beyond the learning curve phase may improve operative time and complication rate 
(Kruijdenberg, 2011). Yan et all (Yan, 2011) presented Twelve-year experience with 
laparoscopic radical hysterectomy and pelvic lymphadenectomy in the study of the 
morbidity, oncological outcome, and prognostic factors of cervical cancer patients treated 
with LRH. According to FIGO stage, the number of patients with stage Ia2, Ib1, Ib2, IIa, and 
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IIb was 2, 163, 34, 35, and 6, respectively. The authors suggests that the short-term follow-up 
in this study was not allow to draw a definitive conclusion on the impact of laparoscopic 
technique on the outcome. More multicenter studies and longterm follow-up were required 
to identify the oncologic outcomes of this procedure (Yan, 2011).  
3.3 Complications of hysterectomy and the quality of life 
A retrospective analysis Davies et all. (Davies, 2002) of 1000 consecutive hysterectomies 
showed that the overall complication rates were 34, 24 and 21% for abdominal, vaginal and 
laparoscopic hysterectomy, respectively. The results show that women undergoing 
hysterectomy for benign indications have a 1:3 to 1:5 chance of developing an operative or 
postoperative complication, most likely of minor nature (Davies, 2002). 
Labrador et all. (Labrador, 2008) analyzed retrospective review of the medical records of 716 
women who had a hysterectomy. Of the 716 hysterectomies, the abdominal (60.34%) route 
was the most common, followed by total laparoscopic hysterectomy (25.84%), vaginal 
hysterectomy (8.38%), Laparoscopic supracervical hysterectomy (3.77%), laparoscopically 
assisted vaginal hysterectomy (1.26%) and Subtotal abdominal hysterectomy (0.42%) routes. 
Patients were an average of 44 years. The 94.97% had benign indications and 5.03% have not 
benign indications. Mean operating time was 112 minutes for total abdominal hysterectomy, 
113.13 minutes for Subtotal abdominal hysterectomy, 131.1 minutes for total laparoscopic 
hysterectomy, 103.73 minutes for Laparoscopic supracervical hysterectomy, 92.41 minutes 
for vaginal hysterectomy and 138.88 minutes for laparoscopically assisted vaginal 
hysterectomy. Blood loss was fewer in vaginal hysterectomies. They found that 
Laparoscopic supracervical hysterectomy and vaginal hysterectomy required less operative 
time and was associated with less blood loss. There were 7 conversions of surgery, 6 
intraoperative bleeding, and 4 urinary tract injuries for total abdominal hysterectomy. For 
total laparoscopic hysterectomy there were 6 urinary tract injuries, and 5 conversion of 
surgery and 1 patient with intraoperative bleeding. Also, 1 patient had a bowel injury for 
vaginal hysterectomy. Blood loss was fewer in vaginal hysterectomies. They found that the 
most important complication was conversion of burgery (Labrador, 2008).  
On the other hand the laparoscopic hysterectomy involves smaller incisions and is less 
painful. Moreover, the hospital stay after laparoscopic surgery may be shorter and the 
risk of infection is lower. Laparoscopic hysterectomy is also a feasible alternative to 
abdominal hysterectomy in obese patients weighing over 100 kg with low morbidity and 
fast recovery and short hospital stay. TLH is associated with significantly longer operative 
time and shorter hospital stay than VH. There is a trend towards more intraoperative and 
postoperative complications in the TLH group than in the VH group (McMaster-Fay, 
2004).  
The laparoscopic hysterectomy is associated with an increased risk of the urinary tract and 
bladder injury and of complications due to general anesthesia. In this retrospective cohort, 
body mass index does not affect surgical outcomes or increase complications during 
laparoscopic assisted hysterectomy. The complications of LAVH performed after prior 
laparotomy includes: damage of the urinary bladder, ureter, intestines and large blood 
vessels, bladder-vaginal and uretero-vaginal fistulas, bleeding from the vaginal stump, 
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postoperative ileus and empyemas of the pelvis. The incidence of these complications is 
estimated at 1.3-12%. Nevertheless, the efficacy of laparoscopy in patients with previous 
surgeries in the peritoneal cavity can amount to even up to 96.9% (Shen, 2003; Ballesta, 
2003).  
It is now widely recognized that in clinical research it is not sufficient to simply measure the 
outcome of a clinical intervention in terms of morbidity and mortality. Recent research 
presents compelling evidence that hysterectomy improves the quality of life. The study 
comparing abdominal or vaginal hysterectomy to endometrial ablative techniques has 
shown consistently higher quality of life scores for hysterectomy. On the other hand, 
retrospective studies suggest that abdominal and particularly vaginal hysterectomy may 
predispose to vault prolapse and the quality of life was lower in these patients compared to 
women after laparoscopic hysterectomy.  
4. General information on vaginal hysterectomy procedures  
4.1 Vaginal hysterectomy  
The vaginal route of hysterectomy is considered as a first choice of all benign indications as 
the post-operative rates of morbidity and complications are lower than abdominal open 
hysterectomies according to the Society of Obstetricians and Gynaecologists of Canada 
(SOGC) clinical guidelines (Lefebvre 2002, Stang 2011). Abdominal hysterectomy involves 
removal of the uterus through an incision on the lower abdomen. Vaginal hysterectomy 
involves removal of the uterus via the vagina, with no abdominal incision. Vaginal 
hysterectomy should be performed in preference to abdominal hysterectomy, where 
possible. The ratio of vaginal hysterectomy (VH) to abdominal hysterectomy (AH) varies 
from 1:3 to 1:4 or less, depending on the country and surgeons' technique. This review 
found that vaginal hysterectomy meant quicker return to normal activities, fewer infections 
and episodes of raised temperature after surgery, and a shorter stay in hospital compared to 
abdominal hysterectomy (Nieboer, 2009; Sheth 2005).  
4.2 Indications and contraindications for vaginal hysterectomy  
There are well-defined indications for both VH. Table 7 present indications and 
contraindications for vaginal hysterectomy.  
Although currently a standard surgery for endometrial cancer is abdominal hysterectomy 
with the excision of appendages and maintenance of oncological sterility, when the 
possibility of abdominal approach is limited (due to severe obesity or internal 
complications), vaginal hysterectomy can be recommended. However, it must be borne in 
mind that it limits the possibility of assessing the actual tumour stage (inability to remove 
the lymph nodes, palpate the small pelvic area and the abdominal cavity and to collect 
cytological smears or washings) (Łapińska-Szumczyk, 2009). A decision to resign from 
lymphadenectomy can be made provided that the patient is qualified into a group of low-
risk recurrence of the disease: histological form of adenocarcinoma endometriale G1 or G2, 
in a situation when the carcinoma is present only in the endometrium or the depth of the 
infiltration does not exceed 50% of the uterine muscularis (Carey, 1995; Mariani, 2000).  
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Indications for vaginal hysterectomy 
Contraindications for vaginal 
hysterectomy 
1. Menorrhagia  
2. Uterine fibroids 
3. Genital and uterine prolapse 
4. Neoplasia 
- Very early invasive cervical cancer 
- Carcinoma-in-situ of the cervix 
- Endometrial cancer 
5. Endometrial complex hyperplasia with atypia 
6. Recurrent postmenopausal bleeding 
7. Chronic pelvic pain 
8. Special indications 
- ventral scar hernioplasty 
- morbid obesity 
- high risk—e.g. interstitial lung disease which 
markedly restricts pulmonary function, poor 
cardiac status, obesity, diabetes, and 
hypertension 
- tuberculous abdomen 
- keloids 
9. common 
- uterus 12 weeks or less in size or uterine 
volume 300 cm3 or less; 
- uterus is freely mobile; and 
- normal adnexa 
1. Common 
- uterus more than 12 weeks’ 
size or uterine volume more 
than 300 cm3 
- restriction of uterine mobility 
- adnexal pathology. 
2. Uncommon 
- cervix flush with the vagina 
- past Fothergill’s operation  
- inaccessible cervix: 
uncommonly, after repeated 
uterine surgery, particularly 
past caesarean section, 
adhesions there are dense 
adhesions between the 
uterocervical surface, the 
bladder and the lower 
abdominal wall which makes 
the cervix inaccessible to an 
approach by the vaginal route 
- vesicovaginal and/or 
rectovaginal fistula repair 
- invasive cancer of the cervix. 
 
Table. 7. Indications and contraindications for vaginal hysterectomy (Sheth, 2005) 
4.3 Complications of hysterectomy and the quality of life 
Nieboer et all (Nieboer, 2009) were included 34 studies with 4495 women. The benefits of 
VH versus AH were speedier return to normal activities (mean difference (MD) 9.5 days), 
fewer febrile episodes or unspecified infections (odds ratio (OR) 0.42), and shorter duration 
of hospital stay (MD 1.1 days). There was no evidence of benefits of LH versus VH and the 
operation time (MD 39.3 minutes) as well as substantial bleeding (OR 2.76) was increased in 
LH. For some important outcomes, the analyses were underpowered to detect important 
differences or they were simply not reported in trials (Nieboer, 2009). 
Meta-analysis of these procedures shows that vaginal hysterectomy results in fewer 
complications than the other types of hysterectomy and is a very safe way to remove the 
uterus. VH is also associated with shorter hospital stay and faster return to normal activities 
than abdominal hysterectomy.  
In another analysis, randomized, non-blinded, three-arm, controlled study it was revealed 
that the length of hospital stay was shorter by 0,9 day for vaginal hysterectomy and by 0,6 
day for laparoscopic assisted vaginal hysterectomy in comparison with total abdominal 
hysterectomy. However the duration of the surgery was longer on average by 13 min for VH 
and 34 min for LAVH (Ottosen, 2000). Ottosen et all. suggested that LAVH might carry a 
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higher risk of conversion to abdominal hysterectomy than vaginal hysterectomy. But in 
opinion Summitt (Summitt, 2002) the relatively small numbers of subjects within each 
surgical group did not allow this conclusion to be made. 
5. Economic analysis 
Economic aspect can be difficult to assess because of the nature of healthcare systems in 
various countries.  
6. Alternatives to hysterectomy 
6.1 The levonorgestrel – Releasing intrauterine system (Mirena, LNG-IUS)  
Conservative alternatives including the Mirena IUS. The levonorgestrel- releasing 
intrauterine system (Mirena, LNG-IUS) is effective in reducing menstrual blood loss and 
should be considered as an alternative to surgical treatment. Surgery, especially 
hysterectomy, reduces menstrual bleeding more than medical treatments at one year but 
LNG-IUS may be comparable in improving quality of life. The evidence for longer-term 
comparisons is weak and inconsistent. Oral medication suits a minority of women long 
term. Randomised controlled trials (RCTs) comparing conservative surgery or hysterectomy 
versus medical therapy (oral or intrauterine) for HMB. Twelve parallel-group RCTs that 
included 1049 women met the inclusion criteria. In comparisons of oral medication versus 
surgery, 58% of the women randomised to medical treatment had received surgery by two 
years. Compared to oral medication, endometrial resection was significantly more effective 
in controlling bleeding (at four months: RR 2.66 (95% CI 1.94 to 3.64); NNT = 2 (95% CI 2 to 
3), one study) and hysterectomy resulted in significantly greater improvements in mental 
health (at six months: P = 0.04, one study). In comparisons of LNG-IUS versus conservative 
surgery or hysterectomy, at one year there was no statistically significant difference in 
satisfaction rates nor in most measures of quality of life, though adverse effects were 
significantly less likely with conservative surgery (RR 0.51 (95% CI 0.36 to 0.74); NNT = 4 
(95% CI 3 to 7), three studies). Conservative surgery was significantly more effective than 
LNG-IUS in controlling bleeding at one year (RR 1.19 (95% CI 1.07 to 1.32); NNT = 7 (95% CI 
5 to 19), five studies). Two small studies with longer follow up found no difference or 
favoured LNG-IUS, but both of these studies had skewed data and there were high losses to 
follow up. Hysterectomy stopped all bleeding but caused serious complications for some 
women (Marjoribanks, 2006).  
6.2 Uterine artery embolization 
Uterine artery embolization is also effective for fibroids and endometrial ablative techniques 
may be an effective therapy for menorrhagia. Uterine artery embolization (UAE) is helpful 
for uterine fibroids that cause symptoms such as heavy bleeding, pain, pressure symptoms 
and subfertility. The two main surgical approaches are myomectomy (hysteroscopic or 
abdominal approach) to remove the fibroids or hysterectomy where the uterus is removed: 
both are associated with complications. There were two randomized controlled trials (RCT) 
comparing UAE with hysterectomy and another comparing UAE with myomectomy. Two 
of these trials had a minimum of six months follow-up and the other is a peri- and 
postprocedural complications report for up to 6 weeks follow-up only. There was no 
evidence of benefit of UAE compared to surgery (hysterectomy / myomectomy) for 
www.intechopen.com
 What Do We Know About Hysterectomy? 
 
405 
satisfaction. There were more minor complications, more unscheduled visits and 
readmission rates after discharge in the UAE group compared to hysterectomy. However, 
there were no differences between major complication rates and UAE is associated with 
shorter hospital stay and return to work. Further research was awaited with long term 
follow up. Women with symptomatic fibroids may be offered UAE as a treatment option but 
more research with a longer follow up is needed (Gupta, 2006). 
6.3 Endometrial hyperplasia can sometimes be treated medically with progestins or 
destruction of endometrial tissue by either TCRE 
Destruction of endometrial tissue by either TCRE (transcervical resection) or ablation is an 
effective alternative to hysterectomy for heavy menstrual bleeding (sometimes defined as a 
loss of 80mls or more of blood per menstrual cycle). Hysterectomy is effective in stopping 
HMB permanently, but also ends fertility and has all the risks of major surgery including 
infection and blood loss. Endometrial resection and other methods of ablation are less 
invasive methods of surgery that aim to remove the entire thickness of the endometrium 
(lining of the uterus). The Cochrane review of trials found TCRE or ablation is an effective 
and possibly cheaper alternative to hysterectomy with faster recovery although re-treatment 
is sometimes needed. There was a significant advantage in favour of hysterectomy in the 
improvement in HMB (OR=0.04, 0.01 to 0.2 at one year) and satisfaction rates (up to four 
years post surgery) (OR=0.5, 0.3 to 0.8 at 2 years) compared with endometrial ablation. 
Duration of surgery, hospital stay and recovery time were all shorter following TCRE or 
endometrial ablation, although these outcomes varied between trials. Most adverse events, 
both major and minor, were significantly more likely after hysterectomy and before 
discharge from hospital. After discharge from hospital, the only difference that was reported 
for this group was a higher rate of infection (OR=0.2, 0.1 to 0.5). Repeat surgery because of 
failure of the initial treatment, either endometrial ablation or hysterectomy, was more likely 
after endometrial ablation than hysterectomy (OR=16.7, 5.8 to 48.6). The total cost of 
endometrial destruction was significantly lower than the cost of hysterectomy but the 
difference between the two procedures narrowed over time because of the high cost of re-
treatment in the endometrial destruction group (Lethaby, 1999). 
7. Conclusions  
- laparoscopic hysterectomy should be considered as an alternative to abdominal 
hysterectomy  
- uterine fibroids are the most common indication for hysterectomy 
- the decision to perform oophorectomy should be individualized 
- subtotal hysterectomy has no advantage over total hysterectomy and might result in 
persistent cyclic bleeding 
- conservative alternatives include the Mirena IUS and uterine artery embolization for 
fibroids and endometrial ablative techniques  
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